Search Results - "Hertfelder, H. J."

The coagulation system of extremely preterm infants: influence of perinatal risk factors on coagulation by Poralla, C, Traut, C, Hertfelder, H-J, Oldenburg, J, Bartmann, P, Heep, A

“…Objective: Little is known about the influence of preterm delivery and perinatal risk factors on development and expression of the coagulation system in…”
Get full text

Standardization of the PFA‐100® platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives by BÖCK, M, DE HAAN, J, BECK, K.-H, GUTENSOHN, K, HERTFELDER, H.-J, KARGER, R, HEIM, M. U, BEESER, H, WEBER, D, KRETSCHMER, V

“…The PFA‐100® (PFA) diagnostic system for the detection of platelet dysfunction was evaluated to determine reference ranges in a normal population. The PFA…”
Get full text

Fibrinolytic function in diuretic-induced volume depletion by Lottermoser, Katja, Hertfelder, H.-J, Vetter, H, Düsing, R

“…Accumulating evidence suggests that the renin-angiotensin system (RAS) may participate in the regulation of fibrinolytic function. In clinical studies,…”
Get full text

Lethal capillary leak syndrome after a single administration of interferon beta-1b by SCHMIDT, S, HERTFELDER, H.-J, VON SPIEGEL, T, HERING, R, HARZHEIM, M, LASSMANN, H, DECKERT-SCHLÜTER, M, SCHLEGEL, U

“…Interferon beta-1b (IFNbeta-1b) is a potent immunomodulatory drug in the treatment of MS. We report a lethal capillary leak syndrome after the administration…”
Get full text

Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness by Molderings, G. J., Dumoulin, F. L., Homann, J., Sido, B., Textor, J., Mücke, M., Qagish, G. J., Barion, R., Raithel, M., Klingmüller, D., Schäfer, V. S., Hertfelder, H. J., Berdel, D., Tridente, G., Weinstock, L. B., Afrin, L. B.

“…Omalizumab is an effective therapeutic humanized murine IgE antibody in many cases of primary systemic mast cell activation disease (MCAD). The present study…”
Get full text

Bleeding diathesis in patients with mast cell activation disease by Seidel, H, Molderings, G J, Oldenburg, J, Meis, K, Kolck, U W, Homann, J, Hertfelder, H-J

Get more information

Missense mutations at ALA‐10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy by Oldenburg, Johannes, Quenzel, Ernst‐Markus, Harbrecht, Uschi, Fregin, Andreas, Kress, Wolfram, Müller, Clemens Rainer, Hertfelder, Hans‐Jörg, Schwaab, Rainer, Brackmann, Hans‐Hermann, Hanfland, Peter

“…Bleeding complications are the most common and unwanted side‐effect of oral anticoagulant therapy. We report three patients in whom mutations in the factor IX…”
Get full text

Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome by Frieling, T, Meis, K, Kolck, U W, Homann, J, Hülsdonk, A, Haars, U, Hertfelder, H-J, Oldenburg, J, Seidel, H, Molderings, G J

“…Previous findings suggested an involvement of mast cells in the pathogenesis of irritable bowel syndrome (IBS). The pathophysiological significance of mast…”
Get more information

Antihypertensive Drug Treatment and Fibrinolytic Function by Lottermoser, Katja, Weisser, Burkhard, Hertfelder, Hans-Jörg, Wöstmann, Bernd, Vetter, Hans, Düsing, Rainer

“…Thromboembolic complications such as ischemic stroke and myocardial infarction are significantly more frequent in patients with arterial hypertension. From the…”
Get full text

Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum by van Ahlen, H, Peskar, B A, Sticht, G, Hertfelder, H J

“…The pharmacokinetics of vasoactive substances injected into the corpus cavernosum for the treatment of erectile dysfunction have not been investigated to date…”
Get more information

Severe bleeding in two patients due to increased sensitivity of factor IX activity to phenprocoumon therapy by QUENZEL, E.-M, HERTFELDER, H.-J, OLDENBURG, J

“…Two male patients with severe and recurrent bleeding episodes under phenprocoumon therapy are reported. Both patients exhibited a strong decrease of their…”
Get full text

The fibrinolytic system in chronic renal failure by Lottermoser, K, Petras, S, Pöge, U, Fimmers, R, Hertfelder, H J, Schiermeyer, B, Vetter, H, Düsing, R

“…Patients with chronic renal failure (CRF) face a high risk of cardiovascular morbidity and mortality. Impaired fibrinolysis has recently been acknowledged to…”
Get more information

Short-time centrifugation at high centrifugal forces in plasma preparation for tPA activity determination by Hertfelder, H J, Popov-Cenic, S

Get more information

Chirurgische Eingriffe bei Patienten mit systemischer Mastzellaktivierungserkrankung: Empfehlungen für das perioperative Management by Sido, B., Homann, J., Hertfelder, H.-J., Zienkiewicz, T., Christians, K.-P., Schablin, P., Mücke, M., Molderings, G. J.

“…Zusammenfassung Hintergrund Die systemische Mastzellaktivierungsserkrankung (MCAD; Prävalenz 5–10 %) ist eine multifaktorielle, polygene Erkrankung mit…”
Get full text

Monogenetische Risikofaktoren einer Thrombophilie by Pavlova, A., Hertfelder, H.-J.

“…Zusammenfassung Die hereditären Thrombophilien gehören zu den angeborenen Prädispositionen, die thrombotische Ereignisse begünstigen. Die wichtigsten…”
Get full text

Surgical interventions in patients with mast cell activation disease. Aspects relevant for surgery using the example of a cholecystectomy by Sido, B, Dumoulin, F L, Homann, J, Hertfelder, H-J, Bollmann, M, Molderings, G J

“…Systemic mast cell activation disease (MCAD) is characterized by an increased and unregulated release of mast cell mediators which can evoke a multifaceted…”
Get full text

Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients by Yadegari, Hamideh, Driesen, Julia, Pavlova, Anna, Biswas, Arijit, Hertfelder, Hans-Jörg, Oldenburg, Johannes

“…Von Willebrand disease (VWD) is the most common inherited bleeding disorder caused by quantitative or qualitative defects of the von Willebrand factor (VWF)…”
Get more information

Studies on low protein C-expression in severe sepsis by Manekeller, S, Hertfelder, H-J, von Spiegel, T, Hering, R, Putensen, C, Schroeder, S

“…Low concentration of protein C in severe sepsis may be associated with increased morbidity and mortality. The present study was designed to clarify to what…”
Get more information

Effects of captopril on fibrinolytic function in healthy humans by Lottermoser, K, Wöstmann, B, Weisser, B, Hertfelder, H J, Schmitz, U, Vetter, H, Düsing, R

“…Several lines of evidence point to an interrelation of the renin angiotensin system (RAS) with the endogenous fibrinolytic system. In the present study, we…”
Get more information

Leukocyte proteinase release during storage of red cell concentrates by Hertfelder, H J, Süwer, V, Popov-Cenić, S, Tschesche, H, Hanfland, P

“…The release of polymorphonuclear leukocyte proteinases in buffy-coat-depleted red cell concentrates was examined during a storage period of 35 days…”
Get more information